Mount Sinai Announces Expanded Capability in Medical Research
New “big omics” supercomputer will speed up solutions; insights will lead to advances in a wide range of complex diseases
Read moreAuthor: sarah Jonas
Platforms Can’t Settle on “Appropriate” Engagement-Boosting Practices
Researchers at Rutgers University say more consistent standards are needed for advertisers, journalists, influencers and marketers seeking to boost their visibility on platforms such as Google, Facebook and Instagram.
Read moreMimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China
Buffalo-based clinical-stage biotechnology company MimiVax, a Roswell Park Comprehensive Cancer Center spinoff, set to work with leading healthcare group in China to provide promising immunotherapy
Read moreLiberal or conservative? CEOs’ political leanings skew firms’ logic in structuring initial pay packages, study shows
Newly appointed, conservative CEOs who are naturally more risk averse receive less performance-based pay than those who are more willing to take risks, and more liberal CEOs get more performance-based pay, according to research from Notre Dame’s Timothy Hubbard.
Read more
ATS, CDC, ERS and IDSA Publish New Clinical Guideline for the Treatment and Prevention of Drug-Resistant Tuberculosis
The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society and the Infectious Diseases Society of America have published an official clinical guideline on the treatment of drug-resistant tuberculosis (DR-TB) in the Nov. 15 American Journal of Respiratory and Critical Care Medicine.
Read more
Ohio State’s Heart and Vascular Center Names 2019 Schottenstein Laureate
The Ohio State University Wexner Medical Center’s Heart and Vascular Center has named Dr. Dan Roden, senior vice president for Personalized Medicine at Vanderbilt University Medical Center, as recipient of the 2019 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
Read moreOpioid prescription doses are increasingly being tapered, often more rapidly than recommended
Stigma and safety fears have made daily dose tapering of opioid prescriptions more common. New research from UC Davis Health physicians, however, shows tapering can occur at rates as much as six times higher than recommended, putting patients at risk of withdrawal, uncontrolled pain or mental health crises.
Read more
David Eccles School of Business EMBA Program ranked No. 21 nationally
The Executive MBA program at the David Eccles School of Business at the University of Utah ranked No. 4 in the West, No. 21 nationally and No. 98 globally by the Financial Times.
Read more
2/3 of Parents cite Barriers in recognizing Youth Depression
Telling the difference between a teen’s normal ups and downs and something bigger is among top challenges parents face in identifying youth depression, a new national poll suggests.
Read more
15-Year Study Finds Treatment Gaps Exist for Patients with Peripheral Arterial Disease; More Consistent Use of Life-Saving Medications Recommended
A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.
Read more
Omega-3 Continues to Show Protection Against Heart Disease-Related Death, Without Prostate Cancer Risk
Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.
Read more
Researchers Discover New Mutations in Gene Associated with Disease That Causes Weakening of the Heart
Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.
Read more